Drug Search Results
More Filters [+]

Triprolidine

Alternative Names: triprolidine, actidil, myidyl, actifed, allerfed, actifed w/ codeine, corphed, triacin-c, histafed, triphed, actahist, trilitron, myfed
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: H1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Australia | Bangladesh | Belgium | Brazil | Chile | Cyprus | Dominican Republic | Egypt | Estonia | France | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Lithuania | Malaysia | Malta | Morocco | New Zealand | Pakistan | Peru | Portugal | Singapore | Slovakia | South Africa | Spain | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Triprolidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title